VRPXVirpax Pharmaceuticals Inc

$0.0005
$0.0001
(25.00%)
Today
Updated: 02:09 PM EDT
Mkt Cap$497.00
Vol240.00

About

Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Virpax Pharmaceuticals Inc?
What is the 52-week high for Virpax Pharmaceuticals Inc?
What is Virpax Pharmaceuticals Inc stock price today?
What was Virpax Pharmaceuticals Inc stock price yesterday?
What is the 50-day moving average of Virpax Pharmaceuticals Inc?

Latest VRPX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.